tiprankstipranks
Neurocrine (NBIX)
NASDAQ:NBIX
US Market
NBIX
Neurocrine
RESEARCH TOOLSreports
Want to see NBIX full AI Analyst Report?

Neurocrine (NBIX) Stock News & Sentiment

1,567 Followers
Beyond Cannabis: 3 Stock Picks Tied to the Psychedelics Trade
Premium
Market News
Beyond Cannabis: 3 Stock Picks Tied to the Psychedelics Trade
2d ago
DFTX
MSOS
3 Different Ways to Play the Rally in Psychedelic Stocks
Premium
Market News
3 Different Ways to Play the Rally in Psychedelic Stocks
7d ago
DFTX
NBIX
Neurocrine Biosciences: Conservative VYKAT XR Outlook and Aggressive Margin Assumptions Justify Hold Rating
Premium
Ratings
Neurocrine Biosciences: Conservative VYKAT XR Outlook and Aggressive Margin Assumptions Justify Hold Rating
10d ago
NBIX
3 Best Trending Stocks, According to Analysts – 4/7/2026
Premium
Market News
3 Best Trending Stocks, According to Analysts – 4/7/2026
24d ago
AMGN
NBIX
Balanced Risk-Reward After Soleno Acquisition Supports Neutral Stance on Neurocrine
Premium
Ratings
Balanced Risk-Reward After Soleno Acquisition Supports Neutral Stance on Neurocrine
24d ago
NBIX
Neurocrine Biosciences: Vykat XR Acquisition Unlocks Diversified Growth and Upside Potential Despite Near-Term Pipeline Lull
Premium
Ratings
Neurocrine Biosciences: Vykat XR Acquisition Unlocks Diversified Growth and Upside Potential Despite Near-Term Pipeline Lull
24d ago
NBIX
Neurocrine’s Soleno Acquisition: Accretive Rare-Disease Expansion Supporting Long-Term Growth and Buy Rating
Premium
Ratings
Neurocrine’s Soleno Acquisition: Accretive Rare-Disease Expansion Supporting Long-Term Growth and Buy Rating
25d ago
NBIX
More NBIX News >

NBIX News on the Web

Wells Fargo downgrades Soleno on pending acquisition
TipRanks News
Neutral
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Galmed Pharmaceuticals (GLMD), Neurocrine (NBIX) and Mesoblast (MESO)
TipRanks News
Bullish
Neurocrine Reports Real-World Data Shows INGREZZA Patients Stay In Treatment Longer
rttnews
Neutral
Neurocrine to present new real-world evidence of Ingrezza use in patients
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ) and Neurocrine (NBIX)
TipRanks News
Neutral
Why Neurocrine’s Stock Is Slumping After Drug Trial
TipRanks News
Bearish
Soleno Therapeutics Stock Rallies 56.4% in a Week: Here's Why
Zacks
Bullish
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
NBIX
Sector Average
Media Buzz
This Week4 articles
Weekly Average10.25 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is NBIX’s Media Buzz Sentiment?
4 articles about NBIX were published this week. In an average week, 10.25 articles are published.
    What is NBIX’s weekly average amount of articles?
    In an average week, 10.25 articles about NBIX are published.
      What is NBIX’s News Sentiment?
      100% of articles about NBIX were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week